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Abstract The available evidence from invitro and in vivo stud-
ies is deemed not sufficient to draw conclusions about the poten-
tial health effects of static magnetic field (SMF) exposure.
Therefore, the aim of the present study was to determine the
influence of static magnetic fields and phloretin on the redox
homeostasis of human dermal fibroblasts. Control fibroblasts
and fibroblasts treatedwith phloretinwere subjected to the influ-
ence of static magnetic fields. Three chambers with static mag-
netic fieldsofdifferent intensities (0.4,0.55, and0.7T)wereused
in the study. Quantification of superoxide dismutase 1 (SOD1),
superoxide dismutase 2 (SOD2), glutathione peroxidase 1
(GPX1), microsomal glutathione S-transferase 1 (MGST1),
glutathione reductase (GSR), and catalase (CAT) messenger
RNAs (mRNAs) was performed by means of real-time reverse
transcriptionPCR(QRT-PCR) technique.Superoxidedismutase
(SOD), glutathione peroxidase (GPx), and catalase (CAT)
activities were measured using a commercially available kit.
No significant differences were found in SOD1, SOD2, GPX1,
MGST1,GSR, andCATmRNAlevels among the studied groups
in comparison to the control culture without phloretin and
without the magnet. There were also no changes in SOD, GPx,
and CATactivities. In conclusion, our study indicated that static
magnetic fields generated by permanent magnets do not exert a
negative influence on the oxidative status of human dermal
fibroblasts. Based on these studies, itmay also be concluded that
phloretin does not increase its antioxidant properties under the
influence of static magnetic fields. However, SMF-induced
modifications at the cellular and molecular level require further
clarification.
Keywords Staticmagnetic field . QRT-PCR . Fibroblasts .
Phloretin . Antioxidant defense system . Redox homeostasis
Introduction
Livingorganismsexist in theEarth’snaturalmagneticfield(MF);
therefore, they are genetically adapted to it. The flux density of
Earth’s constant magnetic field varies between 30 and 60 μT.
Added to that, artificial magnetic fields generated by permanent
magnets are increasingly used in medical imaging, diagnostics,
as well as in consumer devices, such as microphones, speakers,
and home appliances (Saunders 2005; Ghodbane et al. 2013).
MFs have been successfully used inmedicine,mainly in treating
disordersof themusculoskeletal,nervous, respiratory,cardiovas-
cular andocular systems,of thegastrointestinal tract, aswell as in
disorders of skin and soft tissue. The biological effects of MFs,
such as the enhancement of soft tissue repair, or their anti-
inflammatory and anti-edema properties have been established
experimentally, and they constitute a scientific basis for clinical
applicationsofmagnetic fields (Markov2007;Henryet al. 2008;
Ekici et al. 2012). However, the application of MFs in daily life
may carry the risk of functional disorders in cells, tissues, and
biological systems.
Previous studies gave an ambiguous answer as to the poten-
tial harmfulness of the static magnetic field (SMF) to living
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organisms. It has been shown that SMF stimulation has little
effect on cell growth and does not induce genotoxicity
(Miyakoshi 2005). On the other hand, exposure to magnetic
fieldscanincrease theactivityandlifetimeoffreeradicals,which
can lead to oxidative stress (Ghodbane et al. 2013). Enhanced
reactiveoxygenspecies (ROS)productioncanpromotechanges
in the antioxidant enzyme activity, in the regulation of gene
expression, and the intracellular calcium release. Oxidative
stress also modifies the properties of the cell membrane and
influencescellprocessessuchasgrowth,proliferation,anddeath
(Jouni et al. 2012). Moreover, increased oxidative stress may
contribute to the pathogenesis of many diseases, including can-
cer and cardiovascular and skindiseases.Enzymatic andnonen-
zymaticantioxidantdefensesystemsprotect thebodyagainst the
excessive production of reactive oxygen and nitrogen species
(Aprioku 2013). Three levels of the antioxidant defense system
have been described (Lobo et al. 2010; Jebakumar et al. 2012).
The first line contains enzymes such as superoxide dismutase,
catalase, glutathione peroxidase, and glutathione reductase.
They contribute to prevent the formation of free radicals. The
second line of defense involves lipid or water-soluble low-
molecular-weight antioxidants, suchasglutathione,ascorbicac-
id, tocopherol, and flavonoids, which scavenge the active radi-
cals. The third line of defense includes repair enzymes, such as
lipase, proteases, DNA repair enzymes, and transferases (Lobo
et al. 2010; Jebakumar et al. 2012).
Apples and apple-derivedproducts,widespread in the human
diet, are an important source of different biological active sub-
stancessuchasphenoliccompounds(Wangetal.2014).Over the
past few years, researches have demonstrated the unique and
essential roleofphloretin, a flavonoidnaturallypresent inapples,
in regulating many biological processes. Phloretin has been
shown in in vitro studies to inhibit the growth of several cancer
cells, including B16 murine melanoma, HL60 human leukemia
cells, and HT-29 human colon cancer cells (Kobori et al. 1999;
Schaefer et al. 2006). Apart from its anticancer properties asso-
ciated with the induction of apoptosis through the activation of
caspases and the promotion ofBCL2-associatedX (Bax) protein
expression, the antioxidative, antimicrobial, and anti-
inflammatory activities of phloretin have been documented
(Yang et al. 2011; Chang et al. 2012; Barreca et al. 2014). The
antioxidant activity of phloretin has been attributed to its
dihydrochalcone structure. Furthermore, it was demonstrated
that it inhibited the nuclear translocation of nuclear factor
kappa-light-chain-enhancer of activated B cell (NF-κB) subunit
p65 proteins and decreased phosphorylation in mitogen-
activated protein kinase (MAPK) pathways (Chang et al.
2012). Also, phloretin has been shown to suppress matrix
metalloproteinase-1 (MMP-1), the expression of which is in-
volvedinthebreakdownofextracellularmatrix,anditcanprotect
against UV-induced skin damage (Leu et al. 2006; Shin et al.
2014). Therefore, phloretin is believed to have potential to serve
as a preventive agent for ROS-related diseases.
Until now, there have only been a few reports giving an
answer to the question on the effects of static magnetic fields
generated by permanent magnets on human cells. The avail-
able evidence from in vitro and in vivo studies is deemed
insufficient to draw conclusions about the potential health
impact of static magnetic field exposure, because it demon-
strates both positive and negative effects of SMF on cell func-
tioning. Moreover, the mechanism of the influence SMFs ex-
ert on cells still remains unexplained. Therefore, the aim of the
present study was to determine the influence of staticmagnetic
fields of different flux densities (0.4, 0.55, and 0.7 T) and
phloretin on the redox homeostasis of human dermal fibro-
blasts. The activities of antioxidant enzymes and the expres-
sion of genes encoding enzymes involved in the antioxidant
defense system were evaluated.
Material and methods
Cell culture conditions
Normal human dermal fibroblasts (NHDF cell line) were ob-
tained from the Clonetics (CC-2511; San Diego, CA, USA)
and routinely maintained in the fibroblast basal medium
(FBM; Lonza, Basel, Switzerland), supplemented with a hu-
man fibroblast growth factor-basic (hFGF-B), insulin, and
gentamicin (FGM™ SingleQuots™; Lonza, Basel,
Switzerland) at 37 °C in a 5 % CO2 incubator (Heraeus).
Both the cell number and viability were monitored by cell
counting in the Countess TM Automated Cell Counter
(Invitrogen, Carlsbad, CA, USA) after staining with 0.4 %
trypan blue. The experiment was performed on cells in the
logarithmic phase of growth under conditions of ≥98 % via-
bility assessed by trypan blue exclusion. For the experiments,
NHDF cells were used at four to six passages.
Cytotoxicity
Method of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoli-
um bromide (MTT) conversion was used to determine wheth-
er phloretin (Sigma-Aldrich, St Louis, MO, USA) at concen-
trations between 10−8 and 10−3 M was toxic to the fibroblast
cell cultures. Phloretin was prepared as stock solution in di-
methyl sulfoxide (DMSO; Sigma-Aldrich, St Louis, MO,
USA) and then diluted in culture medium. For all experiments,
the final concentration of DMSO in the mediumwas 0.1 % (v/
v). Viability of cells was evaluated after 24 and 72 h of expo-
sure to phloretin. The effect of this flavonoid on cell viability
was evaluated in two independent experiments.
In the MTT assay, the ability of the cells to convert MTT
(Sigma-Aldrich, St Louis, MO, USA) indicates mitochondrial
activity and in consequence cell viability.Normal humandermal
fibroblasts were seeded into 96-well culture plates (Nunc,
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Wiesbaden, Germany) at a density of 5000 cells/well and were
treated with phloretin for 24 and 72 h. For control samples, the
same volume of DMSO without phloretin was added. MTT
(0.25 mg/ml) was added to the medium for 3 h (37 °C) before
the end of the experiment. After being washed with phosphate
buffered saline (PBS), cells were lysed in 100 μl of dimethyl
sulfoxide (Sigma-Aldrich, St Louis, MO, USA) which enabled
the release of the blue reaction product—formazan. Absorbance
at the wavelength of 540 nm was read on a microplate reader
Wallac 1420 VICTOR (PerkinElmer,Waltham,MA, USA).
Exposure of NHDF cells to static magnetic fields
Control fibroblasts and fibroblasts treated with phloretin were
subjected to influence of static magnetic fields. Phloretin was
used in a concentration 10−5M because in the higher concentra-
tion, this compound induced cytotoxic effect as itwas evidenced
before in cell viability assays.
To evaluate the effects of static magnetic fields control and
treated with phloretin, NHDF cells were placed in magnetic test
chambers (patent P—396639,Gawron et al. 2012). Themagnet-
ic chambers used to culture cells in a static magnetic field
consisted of a ferromagnetic yoke, which constituted the bottom
and cover of the chambers and permanent magnets. The cham-
berswereenclosedby lateral, front, andbackwalls; the frontwall
wasfittedwithawindow.Thewindowdimensionscorresponded
to the lateraldimensionsof aculture flask.Nonmagneticdistance
plates determined the inner dimensions of the chambers, which
were matched to the culture flask dimensions.
The design of these test chambers allowed for uniform
distribution of magnetic flux density over the measurement
space of the flask. In our study, three chambers were used,
with three different magnet sizes (6-, 11-, and 20-mm thick).
The flux densities in the chambers were 0.4, 0.55, and 0.7 T,
respectively. The control culture chamber was not equipped
with permanent magnets (steel were used instead) (flux den-
sity of 0.0 T). The cultures were maintained in test chambers
at 37 °C in a 5 % CO2 incubator (Heraeus) for 3 days (72 h).
Next, the cells werewashedwith PBS and cell numberswere
monitored by cell counting in the Countess TMAutomated Cell
Counter (Invitrogen, Carlsbad, CA, USA) after staining with
0.4 % trypan blue. Cells were pelleted and frozen at −70 °C for
24 h until RNA extraction.
RNA extraction
Total RNA was extracted using a TRIzol reagent (Invitrogen,
Carlsbad, CA), according to the manufacturer’s instructions.
RNA extracts were treated with DNase I (RNeasy Mini Kit,
Qiagen, Valencia, CA) according to the manufacturer’s instruc-
tions. The quality of extracts was checked electrophoretically
using 0.9 % agarose gel stained with ethidium bromide (Sigma-
Aldrich, St. Louis,MO).The resultswere analyzed and recorded
using the 1D Bas-Sys gel documentation system (Biotech-
Fisher, Perth, Australia). RNA concentration was determined
using a GeneQuant II RNA/DNA spectrophotometer
(Pharmacia Biotech, Cambridge, UK).
Quantitative RT-PCR assay
Gene expression of SOD1, SOD2,GPX1,MGST1,GSR, CAT,
andβ-actinwas evaluated using real-time reverse transcription
PCR (QRT-PCR) and SYBRGreen I chemistry (SYBR Green
QuantitectRT-PCRKit;QIAGEN,Valencia,CA).Theanalysis
was performed using an Opticon™ DNA Engine Continuous
Fluorescence Detector (MJ Research, Watertown, MA). All
samples were tested in triplicate. β-actin was also included to
monitor the QRT-PCR efficiency, as an endogenous positive
control of amplification and integrityof extracts.Wells contain-
ing no templatewere run as negative controls. Oligonucleotide
primers, specific forSOD1,GPX1,GSR,CAT,were designed
on the basis of reference sequences (GenBank accession No.
NM_000454;NM_000581;NM_000637, andNM_001752,
respectively) using Primer Express TMVersion 2.0 software
(PE Applied Biosystems, Foster City, CA) (Table 1).
Oligonucleotide primers specific for SOD2,MGST1, and β-
actinwere described previously byGottipati andCammarata
(2008), Zenkel et al. (2005), and Strzalka et al. (2008)
(Table 1).
The thermal profile for one-step RT-PCR was as follows: re-
verse transcription at 50 °C for 30min, denaturation at 95 °C for
15 min, and 40 cycles consisting of the following temperatures
and time intervals: 94 °C for 15 s, 60 °C for 30 s, and 72 °C for
30 s. Each run was completed using melting curve analysis to
confirm thespecificityofamplificationand theabsenceofprimer
dimers. RT–PCR products were separated on 6 % polyacryl-
amide gels and visualized with silver salts.
Quantification of expression of target genes
Relativemessenger RNA (mRNA) expression of SOD1, SOD2,
GPX1, MGST1, GSR, and CAT was determined using the
2−(ΔΔCt) method (Livak and Schmittgen 2001), with β-actin as
a reference gene, whereΔCt=Ct of our gene of interest—Ct of
β-actin. The reference gene was validated to determine that the
expressionof this genewas unaffected by the experimental treat-
ment. Gene expression levels of SOD1, SOD2,GPX1,MGST1,
GSR, andCAT in fibroblast-stimulated phloretin and SMFwere
normalized to the expression level in untreated and unexposed
cells.
Biochemical analyses
For biochemical analyses, cellswerewashed twicewith ice-cold
PBS. Next, fibroblasts were mechanically homogenized for
5 min using an Ultra-Turrax homogenizer (IKA Labortechnik,
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Staufen,Germany), in a flaskplacedon ice.Thehomogenization
time was experimentally established by assessing the effective-
ness of the homogenization under amicroscope.All studied bio-
chemical parameters were recalculated to 106 cells.
Superoxide dismutase activity assay
Superoxidedismutase (SOD)activitywasestimatedusingacom-
mercially available kit, RANSOD (Randox Laboratories,
Poland), according to themanufacturer’s instructions. Thismeth-
odemploysxanthineandxanthineoxidase togeneratesuperoxide
radicals, which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-
5-phenyltetrazolium chloride (INT) to form a red formazan dye.
Thesuperoxidedismutase activity is thenmeasuredby thedegree
of inhibition of this reaction. The absorbance at 505 nm was re-
corded for the calculation of SOD activity. One unit (U) of SOD
causes a 50% inhibition of the rate of reduction of INTunder the
conditions of this assay.
Glutathione peroxidase activity assay
Glutathione peroxidase (GPx) activity was measured using a
commercially available kit, RANSEL (Randox Laboratories,
Poland), according to the manufacturer’s instructions. In this
method, glutathione peroxidase catalyzes the oxidation of gluta-
thione by cumene hydroperoxide. In the presence of glutathione
reductase and NADPH, the oxidized glutathione is immediately
converted to its reduced formwith the concomitant oxidation of
NADPH toNADP+. The decrease in absorbance at 340 nmwas
measured.
Catalase activity assay
Catalase (CAT) activity wasmeasured using the Catalase Assay
Kit (Cayman Chemical, MI, USA). The method is based on the
reaction of CAT with methanol in the presence of an optimal
concentrationofH2O2.The formaldehydeproduced ismeasured
spectrophotometrically with 4-amino-3-hydrazino-5-mercapto-
1,2,4-triazole (Purpald) as the chromogen. Purpald specifically
forms a bicyclic heterocycle with aldehydes, which upon oxida-
tion changes from colorless to purple (data not shown).
Lactate dehydrogenase activity assay
Lactate dehydrogenase (LDH) activity was measured using an
assay kit (Sigma-Aldrich, St Louis, MO, USA) according to the
manufacturer’s instruction. The reduction of NAD+ to NADH,
which was catalyzed by lactate dehydrogenase, was exploited in
this assay. The absorbance at 450 nm was recorded for the
calculation of LDH activity. The LDH activity was reported as
the percentage of the control value (data not shown).
Statistical analyses
Statistical analyses were performed using Statistica 9.0 soft-
ware (StatSoft, Tulsa, OK), and the level of significance was
set at p<0.05. Values were expressed as means and standard
deviation (SD) of three independent experiments. The one-
way ANOVA test and Tukey’s post hoc test were applied to
evaluate differences in the expression of examined genes and
in the activity of SOD, GPx, and CAT among studied groups.
Results
Effect of phloretin on NHDF viability
According to the results of a cell viability test, phloretin was not
cytotoxic to the normal human dermal fibroblasts in concentra-
tions between 10−8 and 10−5 M (Fig. 1).
Table 1 Characteristic of primers used for real-time QRT-PCR
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Differences in SOD1, SOD2, GPX1,MGST1, GSR,
and CAT expression level among the studied groups
There was no significant difference in the expression of SOD1
among thecontrol cells, cells exposed toSMFwith0.4,0.55, and
0.7T fluxdensity, and cells treatedwithphloretin and exposed to
SMFs (p>0.05, one-way ANOVA test). No significant differ-
ences were also found for SOD2, GPX1, and GSR among the
studied groups in comparison to the control culture without
phloretin and without the magnet (flux density 0 T) (p>0.05,
one-way ANOVA test). However, the expression of MGST1
was found to be significantly lower after the exposition of cells
to SMFswith 0.4 and 0.55T flux density than in the cells treated
with phloretin and without the magnet (flux density 0 T)
(p=0.008 and p=0.048, respectively, Tukey’s post hoc test). In
turn, the mRNA level of CATwas significantly greater in fibro-
blastsexposed toSMFwith0.7Tfluxdensity than incells treated
with phloretin and without the magnet (flux density 0 T)
(p=0.049, Tukey’s post hoc test) (Table 2).
The effect of the static magnetic fields and phloretin
on the activities of antioxidant enzymes in NHDF cells
In the cultures with phloretin and without static magnetic fields
(control+Ph) and the cultures without phloretin and exposed to
static magnetic fields (6, 11, 20 mm), there were no significant
differences (p>0.05) in SOD activities in comparison with the
control cultures. In thecell cultureswithphloretinandexposed to
static magnetic fields with 0.4, 0.55, and 0.7 T flux density
(6mm+Ph; 11mm+Ph; 20mm+Ph), SODactivitieswere also
not statistically significant in comparison with the control cul-
tures and cultures without phloretin and without static magnetic
fields (Fig. 2).
No significant differences (p>0.05)were also found forGPx
activities in the fibroblast cultures with phloretin and without
SMF (control+Ph), in the cultures without phloretin and ex-
posed to SMF (6, 11, 20 mm), and in fibroblasts treated with
phloretin and exposed to static magnetic fields (6 mm+Ph,
11mm+Ph, 20mm+Ph) compared to the control (Fig. 2).
There were no changes in CAT activities in the studied
fibroblast cultures in comparison with the control ones (data
not presented).
Discussion
The World Health Organization (WHO) recommended
conducting in vitro studies to elucidate the nature of the interac-
tion mechanisms and to help identify the effects of SMF. Such
effects, if present, should thenbe further investigated invivo for a
proper risk evaluation of static magnetic field exposure (WHO
2006). In previous research, effects of static magnetic field have
alreadybeenstudied invitroonvariouscellmodels.However, the
results of these experiments are controversial and do not fully
explain the possible consequences of static magnetic field
exposure.
Static magnetic fields can influence the expression of spe-
cific genes on human and other mammalian cells, and the
effects may depend on the duration of exposure and the
magnetic flux density. The results of Laramee et al. (2014)
revealed that the expression of heat shock protein (HSP70)
in primary rat fibroblasts increased after the exposure to
MFs of 1 to 440 mT. Heat shock proteins are a group of
functionally related molecular chaperones that can be used
as markers for cellular stress (Sõti et al. 2003). Genes related
to cell stress defense mechanisms, including genes encoding
molecular chaperones, antioxidant and pro-oxidant enzymes,
and proteins involved in xenobiotic metabolism, may also be
induced under free radical oxidative stress (Fulda et al. 2010).
Based on the available data, Chekhun et al. (2012) concluded
that the exposure of cells to SMFmay cause disruption of free
radical metabolism and the elevation of their concentration. In
turn, free radical damage can be controlled by the suitable
antioxidant defense systems. However, in our study, SMFs
with different magnetic flux density levels (0.4, 0.55, and
0.7 T) had no or only minor effects on the expression of genes
encoding enzymes involved in the antioxidant defense sys-
tem: SOD1, SOD2, GPX1, MGST1, GSR, and CAT in com-
parison to the control culture. Additionally, no significant
changes in the antioxidant enzyme activity in human fibro-
blasts were observed following the exposure to SMFs.
Nevertheless, findings related to the influence of SMF on the
cell antioxidant activity are contradictory. Lack of any SMF
effect was demonstrated in murine fibroblasts (Glinka et al.
2013), but exposure to 6-mT static magnetic field induced ox-
idative stress in myelomonocytic leukemia cells (U937 cell
Fig. 1 Cell viability in normal human dermal fibroblast cultures exposed
to phloretin (between 10−8 and 10−3 M) for 24 and 72 h. Each bar
represents the mean ± SD of two independent experiments. Statistical
significance, *p< 0.05 vs. control (C)
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line) (De Nicola et al. 2006). Furthermore, our previous studies
conducted in vitro on murine fibroblasts also suggested that
exposure to fluoride and a SMF improves the tolerance of cells
to oxidative stress induced by fluoride ions (Kurzeja et al.
2013). However, this study was only performed at the protein
level, not at the molecular level. Similarly, Traikov et al. (2009)
Table 2 The relative expression of SOD1, SOD2,GPX1,MGST1,GSR,
andCAT inNHDF cells exposed to staticmagnetic fields and inNHDF cells
treated with phloretin, subjected to the influence of static magnetic fields of
different intensities (0.4, 0.55, and0.7T) in comparison to the control culture
without phloretin andwithout themagnet (flux density 0 T)
Relative expression
SOD1 SOD2 GPX1 MGST1 GSR CAT
Control 1.01 ± 0.19 1.00± 0.02 1.01± 0.21 1.01 ± 0.14 1.00± 0.11 1.00 ± 0.12
Control + Ph 0.74± 0.17 1.13± 0.07 0.82± 0.24 1.34 ± 0.11 0.69± 0.09 0.57 ± 0.19
0.4 T 0.71± 0.28 0.94± 0.35 0.67± 0.20 0.84 ± 0.15* 0.73± 0.34 0.70 ± 0.18
0.55 T 0.81± 0.10 1.24± 0.29 0.82± 0.15 0.92 ± 0.33* 0.67± 0.12 0.80 ± 0.28
0.7 T 0.88± 0.16 1.14± 0.13 0.81± 0.20 0.94 ± 0.15 0.71± 0.12 0.95 ± 0.07*
0.4 T +Ph 0.86± 0.13 1.23± 0.22 0.82± 0.02 1.18 ± 0.05 0.57± 0.15 0.59 ± 0.12
0.55 T +Ph 0.95± 0.19 1.09± 0.23 0.85± 0.26 1.17 ± 0.17 0.79± 0.14 0.74 ± 0.08
0.7 T +Ph 0.89± 0.12 1.29± 0.17 0.84± 0.08 1.30 ± 0.20 0.62± 0.58 0.60 ± 0.12
β-actin was used as an endogenous control; means ± SD are presented
Statistical significance: *p< 0.05 vs. cells with phloretin and without magnet (flux density 0 T)
Control—control culture without phloretin and without magnet (flux density 0 T)
Control + Ph—control culture with phloretin (10−5 M) and without magnet (flux density 0 T)
0.4 T—culture without phloretin and with magnet thick 6 mm (flux density 0.4 T)
0.55 T—culture without phloretin and with magnet thick 11 mm (flux density 0.55 T)
0.7 T—culture without phloretin and with magnet thick 20 mm (flux density 0.7 T)
0.4 T +Ph—culture with phloretin (10−5 M) and with magnet thick 6 mm (flux density 0.4 T)
0.55 T +Ph—culture with phloretin (10−5 M) and with magnet thick 11 mm (flux density 0.55 T)
0.7 T +Ph—culture with phloretin (10−5 M) and with magnet thick 20 mm (flux density 0.7 T)
Fig. 2 Effect of the static magnetic fields and phloretin on activities of
antioxidant enzymes in NHDF cells. Each value represents the mean
± SD (n = 5); *p< 0.05 vs. control; #p< 0.05 vs. control + Ph; ^p< 0.05
vs. magnet control (6, 11, 20 mm); control—control culture without
phloretin and without magnet (flux density 0 T); control +Ph—control
culture with phloretin (10−5 M) and without magnet (flux density 0 T);
6 mm—culture without phloretin and with magnet thick 6 mm (flux
density 0.4 T); 11 mm—culture without phloretin and with magnet
thick 11 mm (flux density 0.55 T); 20 mm—culture without phloretin
and with magnet thick 20 mm (flux density 0.7 T); 6 mm+Ph—culture
with phloretin (10−5 M) and with magnet thick 6 mm (flux density 0.4 T);
11 mm+Ph—culture with phloretin (10−5 M) and with magnet thick
11 mm (flux density 0.55 T); 20 mm+ Ph—culture with phloretin
(10−5 M) and with magnet thick 20 mm (flux density 0.7 T)
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indicated that exposure to 25-mT SMF decreased the levels of
inflammatory and stress markers in rat blood plasma. Many
researchers have also observed the lethal effects of moderate
and strong SMFs combined with chemotherapy drugs on
cancer cells such as K562 (human leukemia cells), HTB 63
(melanoma), HTB 77 IP3 (ovarian carcinoma), and CCL 86
(lymphoma, Raji cells) cell lines (Raylman et al. 1996; Sun
et al. 2012). These conclusions point to the future possibility
of clinical application for static magnetic fields in therapy.
The effects of exposure to static magnetic fields are often
difficult to explain, largely due to differences in experimental
parameters such as research conditions, exposure system, ex-
posure times, and magnetic flux density of SMF. In this study,
magnetic test chambers were used, in which cell culture flasks
containing fibroblasts were placed. In the report of Ghodbane
et al. (2011), however, compact electromagnets were applied.
The results of Laramee et al. (2014) also demonstrated that the
response to SMFs was dependent on experimental variables.
These authors suggested that only longer exposure durations
(12–48 h) demonstrate some significant response to SMF.
However, in our study, SMF exposure was maintained for
72 h and we did not observe any significant changes in the
redox homeostasis of human dermal fibroblasts. Moreover, in
our study, the expression of genes encoding enzymes involved
in the antioxidant defense system did not depend on flux den-
sity of static magnetic fields. The dependence on the experi-
mental conditions was also observed by Lahbib et al. (2010),
who found that, in rats, SMF effects on glucose and lipid
metabolism were time-dependent. Likewise, it was observed
that SMF inhibited IL-6 secretion in normal human colon
myofibroblasts and this effect depended on the time of incu-
bation (Gruchlik et al. 2012). However, it is very difficult to
relate research results to human cells, because most research
has been conducted on animal or cancer cells.
It was indicated that phloretin possibly plays a chemopre-
ventive role through modulating the antioxidant and detoxifi-
cation enzyme status (Anand and Suresh 2014). In the present
study, we also strove to determine whether phloretin would
increase its own antioxidant properties under static magnetic
field influence. The addition of phloretin to the cell culture
was manifested by a slightly higher transcriptional activity of
SOD2 and MGST1 and a slightly lower expression of SOD1,
GPX1, GSR, and CAT, in comparison with control cells.
However, these differences were not significant. Likewise,
static magnetic field exposure did not significantly change
the expression of genes encoding enzymes involved in the
antioxidant defense system in human dermal fibroblasts
pretreated with phloretin. The present findings indicated that
phloretin did not increase its antioxidant properties under ex-
posure to SMFs with different flux density influences.
Interestingly, the mRNA level of MGST1 was significantly
lower in cells treated with static magnetic fields of 0.4 and
0.55 T flux densities compared to the control cells treated with
the tested flavonoid, whereas the mRNA level of CAT was
significantly higher under static magnetic field exposure of
0.7 T flux density compared to control cells treated with
phloretin. These observations may indicate that SMFs can
diminish the influence of phloretin on the expression of the
gene encoding a protein localized at the endoplasmic reticu-
lum and outer mitochondrial membrane, where it is thought to
protect these membranes from oxidative stress and the gene
encoding a key antioxidant enzyme (Johansson et al. 2010).
In conclusion, our study indicated that SMFs generated by
permanent magnets do not exert a negative influence on the
oxidative status of human dermal fibroblasts. Based on these
studies, it may be also concluded that phloretin does not in-
crease its antioxidant properties under the influence of SMFs.
However, SMF-induced modifications taking place at the cel-
lular and molecular level require further clarification. Study of
this issue will help to elaborate better treatment strategies for
ROS-related diseases in the future.
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